Joint EFPIA-Roche Event with Representation of the Free State of Bavaria to the European Union

The Revision of the Clinical Trial Directive with Medicinal Products - Opportunity for the next 20 years?

Rue Wiertz 77, 1000 Brussels, 7 March 2012

Dr. Angelika Schlunck, Director of the Representation of the Free State of Bavaria to the European Union

John Dalli, Commissioner for Health and Consumers

The audience

From left to right: Dr. Severin Schwan, CEO F. Hoffmann-La Roche John Dalli, Commissioner for Health and Consumers Anja Weisgerber, Member of the European Parliament/ EPP Dr. Angelika Schlunck, Director of the Representation of the Free State of Bavaria to the European Union

From left to right: Dr. Severin Schwan, CEO F. Hoffmann-La Roche John Dalli, Commissioner for Health and Consumers Anja Weisgerber, Member of the European Parliament/ EPP